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FEV0.75/1.0 = forced expiratory volume at 0.75 s/1.0 s; LRTI = lower respiratory tract infection; PEFR = peak expiratory flow rate; RAD = reactive
airway disease; RSV = respiratory syncytial virus.
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Introduction
Childhood asthma is a serious global public health
problem. According to the World Health Organization [1],
asthma is the most common chronic disease in children. In
some areas of the world the incidence in children is over
50% [1]. Although no single specific cause of asthma has
been found, a number of predisposing factors have been
identified and are the targets of ongoing clinical investiga-
tions. Lower respiratory tract infection (LRTI) caused by
respiratory syncytial virus (RSV) in infancy has been identi-
fied as one such potential risk factor.
Nearly all children are infected with RSV and develop IgG
antibodies to RSV during the first 2 years of life [2].
Although infection is often mild and limited to the upper
respiratory tract, RSV is the leading cause of LRTI world-
wide [2]. As many as 40% of infants may develop bronchi-
olitis or pneumonia, and up to 2% of all infected children
are hospitalized for severe RSV disease every year [3].
Children who are born premature or who have chronic ill-
nesses are at even greater risk for serious infection and
hospitalization from RSV [3].
RSV bronchiolitis is characterized by expiratory wheezing
and respiratory distress [4]. Although multiple studies
[4–17] have reported that infants with RSV bronchiolitis
often develop recurrent wheezy bronchitis and asthma
during childhood, several questions regarding the link
between RSV and reactive airway disease (RAD) must be
addressed. First, is there a direct connection between
severe and/or mild RSV infection and subsequent wheez-
ing/asthma, or are there other factors – perhaps hereditary
or environmental – that might account for a predisposition
to both RSV and RAD? Second, is the severity of infection
predictive of sequelae? In other words, is there a differ-
ence in the risk for subsequent bronchial obstructive
symptoms between children with RSV infection that
requires hospitalization and those with milder infections?
Finally, is there a connection between RSV and subse-
quent allergic sensitization?
Asthma is a leading cause of morbidity and mortality among children worldwide, as is respiratory
syncytial virus (RSV). This report reviews controlled retrospective and prospective studies conducted
to investigate whether there is an association between RSV bronchiolitis in infancy and subsequent
development of reactive airway disease or allergic sensitization. Findings indicate that such a link to
bronchial obstructive symptoms does exist and is strongest for children who experienced severe RSV
illness that requires hospitalization. However, it is not yet clear what roles genetic predisposition and
environmental or other risk factors may play in the interaction between RSV bronchiolitis and reactive
airway disease or allergic sensitization. Randomized, prospective studies utilizing an intervention
against RSV, such as a passive immunoprophylactic agent, may determine whether preventing RSV
bronchiolitis reduces the incidence of asthma.
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This report reviews the available literature that addresses
the potential links between RSV and RAD and between
RSV and allergy/atopy. Both controlled retrospective and
prospective studies are evaluated.
Relationship between RSV bronchiolitis in
hospitalized children and subsequent RAD:
controlled studies
Table 1 provides a summary of available follow-up
studies with control groups in both hospitalized and non-
hospitalized children.
Controlled retrospective studies of infants hospitalized for
RSV LRTI date back several decades. In 1978, Sims et al.
[5] assessed 8-year-old children (n = 35) who had RSV
bronchiolitis in infancy and 35 control children matched
for age, sex, and socioeconomic status [5]. A clinical
history gathered from interviews with parents ascertained
any evidence of wheezing in the children or close relatives,
as well as any allergic rhinitis, urticaria, or smoking among
family members. A physical examination was performed,
including standard respiratory function tests (forced expi-
ratory volume at 0.75 s [FEV0.75], vital capacity, peak expi-
ratory flow rate [PEFR] at rest, and FEV0.75 as a
percentage of vital capacity). In these children, the mean
exercise bronchial lability of the index children was signifi-
cantly greater than that in control children (P < 0.01) and
the mean PEFR at rest was significantly lower (P < 0.02),
although Sims et al. suggested that environmental factors
such as smoking might also play a role.
A subsequent study conducted in 1982 by Pullan and
Hey [6] confirmed those findings, and hypothesized that
some children might be more susceptible to severe
infection because of pre-existing changes in their
airways. These changes could be due to impaired
defense mechanisms or environmental factors, such as
second-hand smoke, family size, or crowded sleeping
arrangements. Those investigators reviewed the records
of 180 children admitted during their first year of life with
confirmed RSV infection. They were able to interview
and examine 130 of the children 10 years later, with a full
pulmonary work-up in 107 children; 111 control children
were also included. Wheezing following LRTI was noted
in 42% of the index children and in 19% of control chil-
dren (P < 0.001); an increase in the incidence of
bronchial lability was also noted in the index children.
Pullan and Hey felt that the increased bronchial lability
may have been related to RSV infection during infancy,
although the link to asthma was unclear. Most excess
wheezing occurred during the first 4 years of life, but
was present in some children up to age 10 years. Indica-
tors of atopy (e.g. eczema, rhinitis, and positive skin
tests) were not found to be more common in index than
in control children. There was no between group differ-
ence in family history of atopy.
Table 1
Studies investigating the link between respiratory syncytial virus bronchiolitis and reactive airway disease
Abnormal 
Number of  Age at follow up  Presence of wheezing/ PFTs in 
Reference Year children (index/control) Hospitalized (years) asthma (index versus control) P (odds ratio) index cases
[5] 1978 35/35 Yes 8 51% versus 3%* <0.0005 Yes
[6] 1982 130/111 Yes 10 42% versus 19%* <0.001 Yes
[8] 1984 100/200 Yes 7 N/A N/A Yes
[15] 1984 59/177 No 8 44% versus 14%† <0.0001 –
[9] 1987 51/24 Yes 2 60% versus 4%† <0.01 –
[10] 1992 73/73 Yes 6 43% versus 15%† <0.001 Yes
[12] 1993 70/70 Yes 2 44% versus 13%† =0.001 –
[4] 1995 47/93 Yes 3 23% versus 1%† <0.001 –
[11] 1997 61/47 Yes 9–10 34% versus 13%† (3.59) Yes
[17] 1999 N/A No 6 N/A (4.3) –
N/A No 13 N/A (1.4; NS) –
[13] 1999 105/105 and 102 Yes 3 N/A NS at age 3 years –
[14] 2000 47/93 Yes 7.5 23% versus 2%† <0.001 –
All numbers were rounded to one significant figure. *Cumulative rates of wheezing/asthma. †Rates in the current year. N/A, no percentages or
figures given; NS, not significant; PFT, pulmonary function test.S10
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In 1982 and 1984, Mok and Simpson [7,8] reported their
findings from a retrospective study of 200 children who
had been hospitalized for LRTI in infancy; 100 of these
children had confirmed RSV disease. Those investigators
compared historical data and ventilatory function in these
children with those of 200 control children at 7 years after
LRTI. Bronchitis and asthma were more common and
more severe in the RSV group. All of the 200 index chil-
dren had bronchial hyperreactivity and abnormal pul-
monary function at follow up, regardless of the type of
LRTI they had been diagnosed with initially. Again, as with
previous studies, no relation with family or personal history
of atopy was identified [8].
Three further studies [9–11] examined whether acute
bronchiolitis was a predictor of reversible obstructive
airway disease. In the earliest of those studies [9], 51
infants hospitalized for acute bronchiolitis over a 2-year
period were included and were examined every 6 months
up to age 2 years. These children were matched with 24
control children. At the first episode of bronchiolitis and at
any time the children were diagnosed with bronchopul-
monary obstruction, nasopharyngeal swabs were col-
lected for virological examination; acute and convalescent
sera were collected to check viral antibody titers. Skin
prick tests were conducted to ascertain allergic status.
Blood tests for IgE, IgG, IgM, IgA, and eosinophil counts
were taken at hospital admission and at age 2 years in
index children, and at age 2 years in control children. Chil-
dren who had been hospitalized for acute bronchiolitis had
twice as many respiratory infections as did control chil-
dren (P < 0.01). By age 2 years, 60% of these children
had three or more episodes of bronchopulmonary obstruc-
tion, as compared with only one child who had symptoms
in the control group. RSV was identified in 61% children
during their initial bout of bronchiolitis. The authors felt
that the viral infection may have damaged the respiratory
tract and increased the likelihood of subsequent severe
illness in these children. They also felt that it was possible
that a structural defect or immaturity of the airways (in
preterm infants) was a predisposing factor for bronchioli-
tis. Those investigators were not able to demonstrate any
factor (including atopy) that separated the index children
from control children in terms of either susceptibility to
acute illness or later symptoms.
In 1992, Murray et al. [10] reported on a cohort of 101
infants admitted to hospital for acute bronchiolitis over the
course of three winter epidemics. Five and a half years
after their initial admission, 73 of the children were re-eval-
uated and matched for age, sex, race, neighborhood, and
history of maternal smoking with 73 control children. Of
the original cohort 66% were RSV positive, whereas at the
follow-up at age 6 years 68% were RSV positive. A further
follow-up study [11] looked at some of these children (61
index cases and 47 control children) after 9.5 years. Index
children at 9 or 10 years after hospitalization coughed
more (48% versus 17%), wheezed more (34% versus
13%), and required more bronchodilators (33% versus
3%) than did control children. Asthma was diagnosed in
39% of index children as compared with 13% of control
children based on those criteria. The results of lung func-
tion testing conducted to assess overall lung growth (i.e.
forced vital capacity, functional residual capacity, total
lung capacity) were not affected in these children.
However, measures of lung function (PEFR, FEV0.75 and
FEV1.0, and airway resistance measured plethysmographi-
cally) indicated the presence of airway obstruction signifi-
cantly more commonly in the index children. Skin tests and
family history failed to support atopy as an explanation for
this inferior lung function or why these children were more
likely to cough and wheeze. The study supported previous
findings that family history of asthma did not predispose
children to wheezing [7]. The only significant predictor of
wheezing was a prior episode of bronchiolitis, often from
RSV infection [10,11].
In 1993, Osundwa et al. [12] conducted a retrospective
study of 70 children who had been hospitalized with RSV
bronchiolitis, matched with 70 control children. All were
reviewed 2 years later and it was discovered that nearly
half (44% of index cases) developed recurrent wheezing,
as compared with only 13% of control children
(P = 0.001). Again, this finding was independent of any
family history of atopy.
Weber  et al. [13] conducted a prospective study that
compared 105 children admitted for RSV LRTI (cohort
group) with 105 children matched for age who were not
admitted to hospital during the same RSV season and
with another control group of 102 children born after the
RSV season. All groups were followed up for the next few
years. Both pneumonia and wheezing were more common
in the cohort group than in both control groups during the
first 2 years. By age 3 years, the rates had fallen to low
levels in all groups and no significant differences were
noted. Thus, for reasons not understood, the rate of post-
bronchiolitic wheezing in that study differs from the rates
reported in other studies.
Sigurs and coworkers [4,14] conducted a prospective
study to evaluate the association between the occurrence
of bronchial obstructive symptoms and IgE antibodies
after RSV bronchiolitis in infancy. The study population
was a cohort of 47 previously healthy infants hospitalized
for RSV bronchiolitis, who were matched for age, sex, and
place of residence with a group of 93 control children.
Children enrolled in the study had a mean age of
3.5 months at the start of the investigation. Children were
examined at ages 1, 3, and 7.5 years for the presence of
asthma and/or allergic sensitization. At age 7.5 years the
cumulative prevalence of asthma was 30% in index casesS11
who had had RSV versus 3% in the control group
(P < 0.001). Current asthma was present in 23% of RSV-
infected children as compared with 2% of the control
group (P < 0.001). Children in the RSV infected group
also had more current atopic asthma (i.e. asthma com-
bined with specific IgE antibodies; 14.9% versus 1%;
P = 0.002). Those children also had higher rates of aller-
gic rhinoconjunctivitis (14.9% versus 2%; P = 0.007). Fur-
thermore, the cumulative prevalence rates for any
wheezing were 68% and 34% (P < 0.001), and the
current prevalence rates for any wheezing at age 7.5 years
were 38% and 2% (P < 0.0001) for cases and controls,
respectively [14]. The RSV group and the control group
were similar in terms of the frequency of atopic dermatitis.
The two groups were compared extensively with regard to
family history of atopy/asthma and other background
factors, and no differences were found.
Relationship between mild RSV bronchiolitis
in infancy and subsequent RAD: controlled
studies
Research conducted in children hospitalized for severe
bronchiolitis or pneumonia secondary to RSV infection
verified the link between this event in infancy and subse-
quent development of RAD [4–14]. However, does such
an association exist for children who had milder RSV
infections and were managed as outpatients?
McConnochie and Roghmann [15] compared 59 children
at age 8 years who had been diagnosed with mild bronchi-
olitis of undetermined etiology during infancy. They
matched 177 control children drawn from a normal pedi-
atric population and found a highly significant difference in
current wheezing (P < 0.0001), with 13.6% of control chil-
dren versus 44.1% of index children experiencing these
symptoms. When other variables (second-hand smoking,
genetic predisposition, etc.) were analyzed, wheezing in
9.4% of the population of children was found to be attribut-
able to bronchiolitis. Likewise, another study [16] reported
the incidence of wheezing among a subpopulation of chil-
dren who had been recruited from the German Multicenter
Atopy Study. Those investigators found that the more
obvious the asthma symptoms, the greater the prevalence
of RSV seropositivity at age 1 year (P = 0.001).
The Tucson Children’s Respiratory Study [17] enrolled a
cohort of 1246 children in infancy and followed some of
them prospectively to age 13 years. Of the 1246 children,
888 were followed for the first 3 years of life. A total of
519 children had at least one pediatrician-diagnosed LRTI
during these 3 years. Of the 472 children who tested pos-
itive for viruses, approximately half (43.9%) were positive
for RSV. Compared with the children in the cohort who
had no LRTIs, children with even mild RSV LRTI had a sig-
nificantly increased risk for frequent wheezing by age
6 years (P < 0.001). The RSV-positive group was 3.2 and
4.3 times more likely to have infrequent wheezing and fre-
quent wheezing, respectively. The increased risk for
wheezing remained statistically significant up to age
11 years but not to age 13. Again, the authors found no
association between RSV infection and atopy.
RSV infections and allergic sensitization
Although IgE antibodies normally comprise a small per-
centage of the total immunoglobulins in the body, they
play an instrumental role in acute allergic reactions. IgE
antibodies are the mediators of the type 1 hypersensitivity
reaction. They cause degranulation of mast cells and
release of histamine and other chemical mediators of the
allergic response, which produce the characteristic wheal
and flare on a positive skin prick test [18]. The relationship
between RSV bronchiolitis and RAD is discussed above.
Another important question is whether RSV and perhaps
other viral respiratory tract infections play any role in sub-
sequent development of allergy in children. The studies
discussed below used serum IgE and/or skin prick tests to
evaluate the relationship between RSV and allergic sensi-
tization (Table 2).
Studies of children with severe RSV infection
Welliver et al. [19] conducted a study of 78 infants who
were hospitalized with RSV bronchiolitis at less than 6
months of age. Nasopharyngeal secretion samples were
tested for the presence of RSV-specific IgE. Acute and
convalescent specimens were obtained. Of those infants
38 were followed until age 4 years [19] and 43 were seen
at age 7 or 8 years [20]. At age 7 or 8 years the children
underwent skin prick testing, pulmonary function tests,
and pulse oximetry readings. Parents were also ques-
tioned regarding passive smoking and any family history of
asthma [20]. The relationship between RSV IgE titer and
subsequent wheezing was then examined using maximal,
convalescent titers obtained approximately 1 month after
the acute infection [19].
The investigators concluded that the RSV IgE titer was
predictive of the risk for developing wheezing from all
causes later in life up to age 4 years. Only three out of 15
children who failed to develop RSV-IgE positive titers sub-
sequently wheezed, as compared with seven out of 10
highly positive children, who had recurrent wheezing.
Infants who fell in the middle of the spectrum in terms of
RSV IgE titers also fell in the middle of the spectrum for
wheezing [19]. By age 7 years, however, RSV IgE titers
noted in infancy did not correlate with lung function or with
the development of specific IgE antibodies to inhaled aller-
gens [20].
The findings reported by Welliver et al. have proved diffi-
cult to repeat. Two additional studies [21,22] found no IgE
antibodies to RSV in the nasopharyngeal secretions of
populations of children hospitalized for RSV infection.
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It is currently unclear what the relationship between RSV
bronchiolitis and allergy may be in children who had been
hospitalized for their infections. One group [10,11] found
an increased risk for allergic sensitization up to age
6 years but could not verify it in the subset of children
tested at age 10 years. Other studies [5,6,9] found no
relationship between RSV bronchiolitis and allergic sensi-
tization. However, the correlation between RSV bronchioli-
tis and allergy is supported by the previously cited studies
by Sigurs and coworkers [4,14]. In those studies, skin
prick tests and serum IgE tests were performed at ages 3
and 7.5 years for common food and inhalant allergens. At
follow up at age 7.5 years, these tests were performed in
44 children who had been hospitalized for RSV LRTI and
89 control children. Allergic sensitization was significantly
higher (P = 0.028) in the RSV group, with 18 out of 44
index cases (41%) versus 19 out of 86 control children
(22%) having positive skin prick and serum IgE tests [14].
Fig. 1 shows allergic sensitization to inhaled allergens at
ages 3 and 7.5 years.
Studies of children with mild RSV infection
Children from the Tucson Children’s Respiratory Study
[17] who had suffered a mild RSV infection, and the
control group in the study by Sigurs et al. [14] who had
had subclinical RSV infection (as confirmed by the pres-
ence of IgG antibodies) were evaluated for atopy using
skin prick tests and tests for specific serum IgE antibod-
ies. No link was found between mild RSV infection and
allergic sensitization at any age. Forster et al. [16] evalu-
ated 609 children, of whom 44.7% had an elevated RSV
IgG titer at age 1 year. They found a slightly increased risk
for sensitization during the first year of life but not later in
the RSV-infected children.
The severity of RSV infection or genetic or environmental
factors could account for the differences observed in the
study populations. It is clear, however, that the evidence
for a connection between RSV infection and allergic sen-
sitization is not conclusive, and further prospective studies
are needed.
Possible predisposing factors for
bronchiolitis and postbronchiolitis symptoms
Although it seems clear that an association exists between
RSV bronchiolitis and RAD, there may be predisposing
factors that place a child at risk for both bronchiolitis and
asthma. A prospective study of children enrolled in the
Tucson Children’s Respiratory Study [23] examined
factors that affect wheezing before age 3 years and their
relation to wheezing at age 6 years. Children under 1 year
Respiratory Research    Vol 3 Suppl 1 Sigurs
Table 2
Studies of the relationship between respiratory syncytial virus and indicators of allergic sensitization
Relationship as 
indicated by 
Number of children  Age at follow up  Serum IgE  positive SPT 
Reference Year (index/control) (years) SPT performed antibody obtained and/or IgE
[6] 1982 130/111 10 Yes No No
[9] 1987 51/24 2 Yes Yes No
[10] 1992 73/73 6 Yes No Yes
[4] 1995 47/93 3 Yes Yes Yes
[14] 2000 47/93 7.5 Yes Yes Yes
[16] 1996 272/337 2 No Yes Yes
[11] 1997 61/47 9–10 Yes No No
[17] 1999 145/445 11 Yes No No
The studies evaluated indicators of allergic sensitization to common inhaled allergens, skin prick tests (SPT), and/or serum IgE antibodies.
Figure 1
Allergic sensitization up to age 7.5 years in 44 children with respiratory
syncytial virus (RSV) bronchiolitis in infancy and 89 control children.
Phadiatop® (Pharmacia Diagnostics, Uppsala, Sweden) is a screening
test for serum IgE antibodies to inhaled allergens. SPT, skin prick test.
Reproduced with permission from Sigurs et al. [14].
0%
10%
20%
30%
40%
RSV Controls RSV Controls
%
of
group
Age 3
Age 7.5
SPT PhadiatopS13
of age with respiratory illnesses who wheezed had evi-
dence of diminished lung function even before exposure to
RSV or other respiratory viral agents. It was hypothesized
that these infants may have smaller airways that predis-
pose them to wheezing, and that bronchial obstructive
symptoms may have a variety of causes earlier in life.
Maternal smoking appeared to be the strongest risk factor
for wheezing, and may have been the causative agent for
smaller lung development.
A prospective, longitudinal study of lung function, airway
responsiveness, and LRTI [24] enrolled 253 infants up to
age 2 years. There was a trend toward pre-existing
reduced lung function in the 17 children who developed
bronchiolitis (two out of 17 with a verified RSV infection).
A follow-up study [25] later re-evaluated 120 members of
this group at age 6 years. There was an increased inci-
dence of asthma in children who had had bronchiolitis
(44% versus 18% in control children) [24]. Airway respon-
siveness to inhaled histamine at a young age was corre-
lated to asthma, poorer performance on spirometry
testing, and lower respiratory tract symptoms in later child-
hood [25]. Those investigators argued that some genetic
or environment factors (e.g. in utero exposure to maternal
smoking) might have caused the initial predisposition to
RAD, and that viral infections and other environmental
insults may have inflicted further damage.
A multivariate analysis in the study by Sigurs et al. [14]
evaluated several possible risk factors for asthma, includ-
ing hereditary predisposition for atopy or asthma, male
sex, exposure to second-hand smoke, and presence of
indoor furred animals. In that study, RSV bronchiolitis was
found to be the most significant risk factor for RAD (odds
ratio 12.7; P < 0.001).
Conclusion
The results of available retrospective and prospective
studies (Table 1) of children with mild to moderate or
severe RSV LRTI show that RSV infection in infancy is
associated with an increased risk for bronchial obstructive
symptoms many years after the infection and that lung
function may be affected for several years. The mecha-
nisms that underlie the connection are not clear, however,
and it is disputed whether some predisposing factor is
necessary for both the development of bronchiolitis and
the subsequent wheezing, or whether the virus itself may
cause postbronchiolitic symptoms. It is also possible that
some predisposing factor(s) and the virus both contribute
to the RAD [26]. One such predisposing factor could be a
pre-existing diminished lung function before a respiratory
virus is encountered. However, according to available
studies, it appears certain that a family history of atopy
and/or asthma does not explain the RAD symptoms that
occur following RSV LRTI.
The connection between RSV LRTI and allergic sensitiza-
tion is not as clear as the link between RSV and RAD,
because the results of available studies differ (Table 2). The
relationship between RSV and RAD suggests that preven-
tive measures may be useful in reducing risk for asthma.
Long-term, prospective, and randomized studies are
needed to clarify whether prevention of severe RSV disease
reduces the subsequent development of asthma and
allergy. Use of currently available prophylactic agents such
as palivizumab might offer a way to study the relationship
between severe RSV infection and subsequent asthma.
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